NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 53 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16 | -99.9% | 47,916 | +25.9% | 0.00% | – |
| Q3 2022 | $16,000 | -42.9% | 38,068 | +74.0% | 0.00% | – |
| Q4 2021 | $28,000 | -80.1% | 21,880 | -68.1% | 0.00% | – |
| Q3 2021 | $141,000 | -72.4% | 68,623 | -78.8% | 0.00% | – |
| Q2 2021 | $511,000 | +1281.1% | 323,364 | +1834.9% | 0.00% | – |
| Q1 2021 | $37,000 | -95.9% | 16,712 | -95.7% | 0.00% | -100.0% |
| Q1 2020 | $909,000 | +20.1% | 388,656 | +13.0% | 0.00% | +100.0% |
| Q4 2019 | $757,000 | -9.6% | 344,057 | -24.4% | 0.00% | 0.0% |
| Q3 2019 | $837,000 | -50.0% | 455,094 | -60.6% | 0.00% | -66.7% |
| Q2 2019 | $1,674,000 | – | 1,154,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |